These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1690279)

  • 61. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Liquid-phase binding assay of alpha-fetoprotein using a sulfated antibody for bound/free separation.
    Nakamura K; Imajo N; Yamagata Y; Katoh H; Fujio K; Tanaka T; Satomura S; Matsuura S
    Anal Chem; 1998 Mar; 70(5):954-7. PubMed ID: 9511471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-specific tumoral markers in hepatocellular carcinoma.
    Stanciu L; Dumitraşcu D; Radu D; Badea R
    Med Interne; 1990; 28(2):139-44. PubMed ID: 1702896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S; Khan AA; Tarique S
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
    Chan SL; Chan AT; Yeo W
    Future Oncol; 2009 Aug; 5(6):889-99. PubMed ID: 19663737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
    Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
    Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
    Amery AH; Alston WC; Kohn J; White WF
    Br Med J; 1977 Sep; 2(6087):611-2. PubMed ID: 71184
    [No Abstract]   [Full Text] [Related]  

  • 71. Immune complex transfer enzyme immunoassays for anti-angiotensin I IgG in serum using angiotensin I conjugates prepared by two different methods.
    Kohno T; Yamaguchi K; Ishikawa E
    J Biochem; 1990 Nov; 108(5):741-7. PubMed ID: 2127930
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later].
    Molina Infante J; Pérez Gallardo B; Prieto Bermejo AB; Fernández Bermejo M; Robledo Andrés P
    Gastroenterol Hepatol; 2007; 30(6):370-1. PubMed ID: 17662222
    [No Abstract]   [Full Text] [Related]  

  • 73. Fucosylation of alpha-fetoprotein in hepatocellular carcinomas.
    Buamah PK; Cornell C; Cassells-Smith AJ; Harris AL
    Lancet; 1986 Apr; 1(8486):922-3. PubMed ID: 2421123
    [No Abstract]   [Full Text] [Related]  

  • 74. Two-site enzyme immunoassay for alpha-fetoprotein in dried-blood samples collected on filter paper.
    Tsao D; Hsiao KJ; Wu JC; Chou CK; Lee SD
    Clin Chem; 1986 Nov; 32(11):2079-82. PubMed ID: 2430735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High serum levels of secretory component in hepatocellular carcinoma.
    Kew MC; Vincent C; Rossel M; Revillard JP
    Am J Med; 1988 Sep; 85(3):327-30. PubMed ID: 2458039
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum alpha-fetoprotein in experimental hepatocellular carcinomas in rats.
    Gopal Naidu NR; Aikat BK; Dash RJ; Sehgal S
    Eur J Cancer (1965); 1978 Mar; 14(3):295-301. PubMed ID: 75796
    [No Abstract]   [Full Text] [Related]  

  • 77. More sensitive and simpler immune complex transfer enzyme immunoassay for antithyroglobulin IgG in serum.
    Kohno T; Mitsukawa T; Matsukura S; Tsunetoshi Y; Ishikawa E
    J Clin Lab Anal; 1989; 3(3):163-8. PubMed ID: 2502610
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection of one milliattomole of ferritin by novel and ultrasensitive enzyme immunoassay.
    Hashida S; Ishikawa E
    J Biochem; 1990 Dec; 108(6):960-4. PubMed ID: 2128491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum alpha-fetoprotein in nonneoplastic liver diseases.
    Bloomer JR
    Dig Dis Sci; 1980 Apr; 25(4):241-2. PubMed ID: 6156062
    [No Abstract]   [Full Text] [Related]  

  • 80. Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
    Brouillet JP; Hanslick B; Maudelonde T; Pivat MT; Grenier J; Blanc F; Rochefort H
    Clin Biochem; 1991 Dec; 24(6):491-6. PubMed ID: 1663431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.